Prime Medicine (PRME) announced the appointment of Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer, CBO. Most recently, Hawryluk served as Chief Business Officer at AIRNA Corporation
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRME:
- Intellia Therapeutics price target lowered to $9 from $14 at Wedbush
- Prime Medicine price target raised to $5 from $4 at Citi
- PRME Earnings this Week: How Will it Perform?
- Cathie Wood Loads Up on Klarna, Synopsys, and Rubrik, Trims Shopify and Roblox Stocks
- Cathie Wood’s ARK Investment buys 231K shares of Prime Medicine today